Personalised melanoma vaccine cuts risk of death or recurrence by 42%

Melanoma vaccine trial results

The Irish News reported that the world's first personalised mRNA cancer jab for melanoma, paired with Keytruda, cut the risk of death or recurrence by 42% after two years. Bloomberg noted that oncologists cheered the data even as Moderna's shares fell. The New York Times said scientists are also studying the approach in other cancers.

Reported by The Irish News
Reported by The New York Times
Reported by The Daily Telegraph

Second Ebola death in Kenya

The Philadelphia Inquirer reported that Kenya's health ministry announced the country's second Ebola death, a 65-year-old woman who was a close relative of the first patient. Seven other patients remain in isolation.

Reported by Philadelphia Inquirer

Psoriasis pill approved in UK

Reuters reported that the UK approved Johnson & Johnson's oral psoriasis pill.

Reported by Reuters

Breast cancer drug shows long-term benefit

Reuters reported that Novartis' breast cancer drug cut the risk of death by 19% after six years, based on new data.

Reported by Reuters

Recall on compound GLP-1 drugs

The Hill reported a nationwide recall on compounded GLP-1 drugs, which are not FDA-approved nor name-brand.

Reported by The Hill News

Alzheimer's blood test development

The Times reported on a UK institute that is developing an Alzheimer's disease blood test.

Reported by The Times

Sugar disrupts gut microbiome during antibiotics

Science News reported that a study in Nature found that sugar-rich foods exacerbate antibiotic-induced disruption of the gut microbiome.

Reported by Science News

Checked

12 claims in this story checked against 5 sources: 4 supported.

Show each claim

Partly supportedThe melanoma vaccine reduced the risk of death or recurrence by 42%.The Irish News: “World’s first mRNA cancer jab for melanoma cuts risk of death by 42%.”
Not in the sourcesThe melanoma vaccine was personalised.The Irish News
Not in the sourcesThe melanoma vaccine was paired with Keytruda.The Irish News
Not in the sourcesThe 42% reduction was measured after two years.The Irish News
SupportedBloomberg reported that oncologists cheered the melanoma data as Moderna’s shares fell."site:bloomberg.com when:1d" - Google News: “Oncologists Cheer Melanoma Data That Tanked Moderna’s Shares - Bloomberg.com.”
Not in the sourcesThe New York Times said scientists are studying the approach in other cancers.NYT > Business
SupportedKenya reported a second Ebola death.Philadelphia Inquirer: “Kenya announces 2nd Ebola death, a close relative of the first patient.”
Not in the sourcesKenya’s health ministry announced the second Ebola death.Philadelphia Inquirer: “Kenya announces 2nd Ebola death, a close relative of the first patient.”
Not in the sourcesThe second Ebola patient was a 65-year-old woman.Philadelphia Inquirer
Not in the sourcesSeven other Ebola patients remained in isolation.Philadelphia Inquirer
SupportedThe UK approved Johnson & Johnson’s oral psoriasis pill."site:reuters.com/business when:1d" - Google News: “UK approves J&J's oral psoriasis pill - Reuters.”
SupportedNovartis’ breast cancer drug cut the risk of death by 19% after six years."site:reuters.com/business when:1d" - Google News: “Novartis' breast cancer drug cuts risk of death by 19% after six years, data shows - Reuters.”